ArticleScientific reports2021

High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma.

Katja Tuomainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.